(주)쓰리에이치바이오

{
  "address": "경기도 성남시",
  "ceo_name": "최문경, 김형지",
  "certificate": [
    {
      "cert_number": "20200402188",
      "changes": "",
      "disclosure_date": "2020-09-21",
      "first_cert_date": "2020-09-21",
      "no": "1",
      "type": "기술평가대출기업(중진공)",
      "valid_period": "2020-09-21 ~ 2022-09-20"
    },
    {
      "cert_number": "20220928010037",
      "changes": "",
      "disclosure_date": "2022-09-28",
      "first_cert_date": "2020-09-21",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-09-21 ~ 2025-09-20"
    },
    {
      "cert_number": "20250909010033",
      "changes": "",
      "disclosure_date": "2025-09-09",
      "first_cert_date": "2020-09-21",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-09-21 ~ 2028-09-20"
    }
  ],
  "company_name": "(주)쓰리에이치바이오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 141495000,
      "cost_of_sales": 0,
      "current_assets": 1857111000,
      "current_liabilities": 65788000,
      "gross_profit": 0,
      "net_income": -760842000,
      "net_income_bs": -760842000,
      "non_current_assets": 542847000,
      "non_current_liabilities": 167529000,
      "non_operating_expenses": 16850000,
      "non_operating_income": 4928000,
      "operating_profit": -748920000,
      "revenue": 0,
      "sga_expenses": 748920000,
      "total_assets": 2399958000,
      "total_equity": 2166641000,
      "total_liabilities": 233317000
    },
    "2023": {
      "capital_stock": 141495000,
      "cost_of_sales": 0,
      "current_assets": 72104000,
      "current_liabilities": 1113921000,
      "gross_profit": 13208000,
      "net_income": -1355435000,
      "net_income_bs": -1355435000,
      "non_current_assets": 2836818000,
      "non_current_liabilities": 626449000,
      "non_operating_expenses": 20749000,
      "non_operating_income": 20885000,
      "operating_profit": -1355571000,
      "revenue": 13208000,
      "sga_expenses": 1368779000,
      "total_assets": 2908922000,
      "total_equity": 1168552000,
      "total_liabilities": 1740370000
    },
    "2024": {
      "capital_stock": 159706000,
      "cost_of_sales": 0,
      "current_assets": 1800262000,
      "current_liabilities": 147862000,
      "gross_profit": 21692000,
      "net_income": -1908880000,
      "net_income_bs": -1908880000,
      "non_current_assets": 4023453000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 41901000,
      "non_operating_income": 2249000,
      "operating_profit": -1869228000,
      "revenue": 21692000,
      "sga_expenses": 1890920000,
      "total_assets": 5823715000,
      "total_equity": 5675853000,
      "total_liabilities": 147862000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "500,004,400",
      "changes": "500,004,400",
      "date": "2023-09-16"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-07-28"
    }
  ],
  "main_products": "비만면역치료제 연구 개발",
  "phone": "031-717-****",
  "years": [
    2024,
    2023,
    2022
  ]
}